Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Sequential and Concurrent Chemoradiation for Patients With Advanced Nasopharyngeal Carcinoma (NPC)

NCT00896181 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00896181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00896181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Sequential and Concurrent Chemoradiation for Patients With Advanced Nasopharyngeal Carcinoma (NPC)
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
December 10, 2008
Completion date
December 31, 2020
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii lymphoepithelioma of the nasopharynx, stage ii squamous cell carcinoma of the nasopharynx, stage iii lymphoepithelioma of the nasopharynx, stage iii squamous cell carcinoma of the nasopharynx, stage iv lymphoepithelioma of the nasopharynx, stage iv squamous cell carcinoma of the nasopharynx